Breast Biopsy Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023
- Transparency Market Research
- Medical Equipments
Breast Biopsy tests are used largely for diagnosing breast cancer and also as a preventive checkup for breast cancer and other ailments in the breast, such as lump etc. identified during physical examination. The Breast Biopsy market can be segmented based on technique type. The various different techniques for Breast Biopsy are Fine needle aspiration biopsy, which is one of the minimal invasive procedure, usually without scarring. In this procedure, a needle is inserted in breast through the breast dermal tissue to remove the tissue sample. The other technique, involves an ultrasound-guided biopsy where ultrasound radiations are used, alternatively known as stereotactic needle biopsy along with a mammogram. During this procedure, the needle placed on the ultrasound monitor guides it to the target site in breast. In stereotactic mammography, images from different angles are used to accurately detect the location from breast mass, where a hollow needle insertion is made for the sample.
The third technique is known as core needle biopsy, which involves a relatively larger size hollow needle compared to fine needle aspiration. Thereafter, this large hollow needle removes multiple samples, which are cylinder-shaped from the specific area in breast tissue. Another form of breast biopsy is similar to a surgical procedure, known as Incisional Biopsy, which involves a local anesthesia followed by a tissue removal through a surgical operation in breast. Similarly, there is another technique of breast biopsy involving a surgical procedure known as excisional biopsy. During this procedure, the entire portion of breast tissue that is susceptible of suspected cancer is removed surgically and in addition, a small rim of normal tissue surrounding the suspicious area is removed as a preventive measure, also known as a marg. The most advanced and innovative form of breast biopsy is the vacuum assisted breast biopsy, commonly known with a brand name Mammotone. A special probe is inserted once to remove tissue mass more than the core needle procedure in the vacuum assisted procedure.
Some of the major drivers in this market are increasing level of awareness and higher incidence of breast cancer. Other factors include higher prevalence of breast cancer among post-menopausal women. Thus, in countries where there are higher proportions of women above 40 age group would be potential markets for breast cancer screening and diagnosis. The restraints in this market include high cost of procedure and demand skewed towards specific gender and middle age to elderly age group, eliminating a major chunk of the population segment.
Geographically, it was observed that in the United States, only 20% of the breast biopsy cases during the screening programs were detected with cancer. Therefore, the probability sharply varies across different countries and regions. However in countries like Sweden only the suspicious lesions in breast tissue were biopsied. The outcome of the total breast biopsies in screening programs was sharply different from U.S., 80% of the total breast biopsies had cancers and malignancies.
Another striking feature of the breast biopsy market is that nearly 70 percent of the total breast biopsies deploy surgical procedures, which means that there is a huge demand for surgical techniques compared to needle based breast biopsies. The possible explanation behind this trend is attributable to the fact that surgical Breast Biopsies have a much higher validity for confirming breast cancer compared to needle based biopsies. It has been observed that there are many women who despite of not having any confirmation for breast cancer take this surgery to eliminate any risks of breast cancer. Therefore, there is certainly a clear market demand among those undergoing these surgeries as a preventive measure for protection against any susceptible form of breast cancer.
Some of the key players operating in the Breast Biopsy market include Biomed Diagnostics, Inc., Bard Peripheral Vascular Inc., F. Hoffmann-La Roche Ltd., Hologic Inc., Intact Medical, Mammotome, OncoCyte Corporation, Laboratory Corporation of America Holdings (Labcorp) among others.
This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. This report provides comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Reasons for Buying this Report
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a six-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
- It provides distinctive graphics and exemplified SWOT analysis of major market segments
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Medical Equipments
Medical DevicesNebulizers-Medical Devices Pipeline Product Landscape, 2021